Cargando…
Human Parvovirus 4 Infection, Cameroon
In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C...
Autores principales: | Lavoie, Myriam, Sharp, Colin P., Pépin, Jacques, Pennington, Christopher, Foupouapouognigni, Yacouba, Pybus, Oliver G., Njouom, Richard, Simmonds, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309673/ https://www.ncbi.nlm.nih.gov/pubmed/22469425 http://dx.doi.org/10.3201/eid1804.110628 |
Ejemplares similares
-
Epidemiology of Human Parvovirus 4 Infection in Sub-Saharan Africa
por: Sharp, Colin P., et al.
Publicado: (2010) -
Serodiagnosis of Primary Infections with Human Parvovirus 4, Finland
por: Lahtinen, Anne, et al.
Publicado: (2011) -
Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing
por: Iles, James C., et al.
Publicado: (2015) -
Human Parvovirus 4 as Potential Cause of Encephalitis in Children, India
por: Benjamin, Laura A., et al.
Publicado: (2011) -
Endemicity and genetic diversity of Hepatitis delta virus among Pygmies in Cameroon, Central Africa
por: Foupouapouognigni, Yacouba, et al.
Publicado: (2022)